**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 865-49-6 |Chloroform-D | | 212-742-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22 38 40 48/20/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to skin. Limited evidence of a
carcinogenic effect. Harmful : danger of serious damage to health by
prolonged exposure through inhalation and if swallowed.Light
sensitive.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Vapors may cause eye irritation. Contact produces irritation,
tearing, and burning pain. May cause conjunctivitis. Causes
redness and pain.
Skin:
Prolonged and/or repeated contact may cause irritation and/or
dermatitis. May cause severe skin irritation with possible burns,
especially if skin is wet or moist. Causes redness and pain.
Ingestion:
Harmful if swallowed. May cause central nervous system depression,
kidney damage, and liver damage. May cause gastrointestinal
irritation with nausea, vomiting and diarrhea. May cause cardiac
disturbances.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes respiratory tract irritation. May cause liver and
kidney damage. May cause cardiac sensitization and possible failure.
May cause narcotic effects in high concentration.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Prolonged or repeated skin contact may cause dermatitis. Prolonged or
repeated exposure may cause adverse reproductive effects. May cause
liver and kidney damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Immediately flush skin with plenty of water for at least 15 minutes
while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out
with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Use extinguishing media appropriate to the surrounding fire.
Substance is noncombustible.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Do not ingest or inhale.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under an inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower.
Exposure Limits
CAS# 865-49-6:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: sweetish odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 60.8 deg C @760mmHg
Freezing/Melting Point: -64 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.500
Molecular Formula: CCl3D
Molecular Weight: 120.39
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
High temperatures, incompatible materials, light, moisture.
Incompatibilities with Other Materials:
Strong oxidizing agents, bases, alcohols, aluminum, fluorine,
magnesium, sodium hydroxide, potassium, lithium, methyl alcohol,
sodium, caustics (e.g. ammonia, ammonium hydroxide, calcium
hydroxide, potassium hydroxide, sodium hydroxide), ketones (e.g.
acetone, acetophenone, MEK, MIBK), acetone, dinitrogen tetraoxide,
potassium hydroxide, perchloric acid, potassium-tert-butoxide,
phosphorus pentoxide, sodium potassium alloys, calcium hydroxide.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide, chlorine,
phosgene gas.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 865-49-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Chloroform-D -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Toxic to Daphnia: >1000 mg/l Fish-toxicity: 162 mg/l
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CHLOROFORM
Hazard Class: 6.1
UN Number: 1888
Packing Group: III
IMO
Shipping Name: CHLOROFORM
Hazard Class: 6.1
UN Number: 1888
Packing Group: III
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 38 Irritating to skin.
R 40 Limited evidence of a carcinogenic effect.
R 48/20/22 Harmful : danger of serious damage to
health by prolonged exposure through inhalation and if
swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 865-49-6: No information available.
Canada
CAS# 865-49-6 is listed on Canada's DSL List.
CAS# 865-49-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 865-49-6 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/03/2003 Revision #0 Date: Original.
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Potassium Hexamethyldisilazide
| 40949-94-8 |
|
2-Methoxybenzyl chloride
| 7035-02-1 |
|
Pivaldehyde, 98%
| 630-19-3 |
|
Decahydronapthalene-D18, 99 atom% D
| 28788-42-3 |
|
4'-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)acetanilide
| 214360-60-8 |
|
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
| 269409-73-6 |
|
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
| 210907-84-9 |
|
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
| 191171-55-8 |
|
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 97%
| 269409-97-4 |
|
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
| 214360-76-6 |
|
DL-Terebic Acid, 98+%
| 79-91-4 |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 97%
| 269409-70-3 |
|
Cobalt, certified powder, mesh 300 and finer
| 7440-48-4 |
|
2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
| 269410-22-2 |
|
2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
| 269410-25-5 |
|
N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]succinamic
| 480424-98-4 |
|
N-Nitrosodimethylamine, 99+%
| 62-75-9 |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
| 181219-01-2 |
|
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
| 329214-79-1 |
|
4-Acetamidophenylboronic acid
| 101251-09-6 |
|
3-Acetamidophenylboronic acid
| 78887-39-5 |
|
Chloroform-D, stabilized with silver foil, contains 0.03 v/v% TMS,
| 865-49-6 |
|
2-Chloro-6-fluorobenzonitrile, 98%
| 668-45-1 |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid
| 180516-87-4 |
|
Methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
| 00-01-1 |
|
Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
| 195062-62-5 |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
| 171364-82-2 |
|
3-Methyl-1-phenyl-2-pyrazolin-5-one 99%
| 89-25-8 |
|
Diethylphosphatoethyltriethoxysilane
| 757-44-8 |
|
2',4'-Dimethoxyacetophenone
| 829-20-9 |
|
Diethyl maleate, remainder max. 1.5% diethyl fumarate
| 141-05-9 |
|
Tri-tert-butylphosphine tetrafluoroborate
| 131274-22-1 |
|
Methyl 2-oxocyclohexanecarboxylate
| 41302-34-5 |
|
2-Iodobiphenyl
| 2113-51-1 |
|
Calcium thioglycolate trihydrate
| 814-71-1 |
|
(R)-(+)-1-(4-Bromophenyl)ethylamine hydrochloride
| 64265-77-6 |
|
Trifluoromethanesulfonic anhydride
| 358-23-6 |
|
4-Octylbenzaldehyde, 97%
| 49763-66-8 |
|
1,1,1-Trichloroethane, 90%
| 71-55-6 |
|
alpha-D-Lactose monohydrate, USP/NF, Ph.Eur., JP
| 5989-81-1 |
|
3-Heptyn-1-ol
| 14916-79-1 |
|
3-Octyn-1-ol
| 14916-80-4 |
|
3-Butyn-2-ol
| 2028-63-9 |
|
1-Chloro-2,4-dimethoxybenzene
| 7051-13-0 |
|
4-Amino-3,5-dichloropyridine
| 22889-78-7 |
|
O-(Trimethylsilyl)hydroxylamine
| 22737-36-6 |
|
4-Fluoro-DL-alpha-phenylglycine
| 7292-73-1 |
|
3-Carene
| 99-86-5 |
|
4-Bromo-3-methylphenol
| 14472-14-1 |
|
Ethyl 4-methyl-5-imidazolecarboxylate, 98%
| 51605-32-4 |
|
|